BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37459511)

  • 1. IL-7R licenses a population of epigenetically poised memory CD8
    Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
    Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of CD8
    O'Melia MJ; Rohner NA; Manspeaker MP; Francis DM; Kissick HT; Thomas SN
    Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33310857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.
    Han J; Zhao Y; Shirai K; Molodtsov A; Kolling FW; Fisher JL; Zhang P; Yan S; Searles TG; Bader JM; Gui J; Cheng C; Ernstoff MS; Turk MJ; Angeles CV
    Nat Cancer; 2021 Mar; 2(3):300-311. PubMed ID: 34179824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fructose-mediated adipocyte metabolism drives antitumor CD8
    Zhang Y; Yu X; Bao R; Huang H; Gu C; Lv Q; Han Q; Du X; Zhao XY; Ye Y; Zhao R; Sun J; Zou Q
    Cell Metab; 2023 Dec; 35(12):2107-2118.e6. PubMed ID: 37863051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.
    Kim H; Feng Y; Murad R; Pozniak J; Pelz C; Chen Y; Dalal B; Sears R; Sergienko E; Jackson M; Ruppin E; Herlyn M; Harris C; Marine JC; Klepsch V; Baier G; Ronai ZA
    Sci Adv; 2023 Jul; 9(27):eadf6621. PubMed ID: 37406115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function.
    Wang Y; Zhao G; Wang S; Li N
    MedComm (2020); 2024 May; 5(5):e552. PubMed ID: 38645666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis.
    Lenk L; Baccelli I; Laqua A; Heymann J; Reimer C; Dietterle A; Winterberg D; Mary C; Corallo F; Taurelle J; Narbeburu E; Neyton SL; Déramé M; Pengam S; Vogiatzi F; Bornhauser B; Bourquin JP; Raffel S; Dovhan V; Schüler T; Escherich G; den Boer ML; Boer JM; Wessels W; Peipp M; Alten J; Antić Ž; Bergmann AK; Schrappe M; Cario G; Brüggemann M; Poirier N; Schewe DM
    Blood; 2024 Mar; ():. PubMed ID: 38518105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in IL-7 Research on Tumour Therapy.
    Fu C; Zhang X; Zhang X; Wang D; Han S; Ma Z
    Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
    Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
    Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors.
    Castiglioni A; Yang Y; Williams K; Gogineni A; Lane RS; Wang AW; Shyer JA; Zhang Z; Mittman S; Gutierrez A; Astarita JL; Thai M; Hung J; Yang YA; Pourmohamad T; Himmels P; De Simone M; Elstrott J; Capietto AH; Cubas R; Modrusan Z; Sandoval W; Ziai J; Gould SE; Fu W; Wang Y; Koerber JT; Sanjabi S; Mellman I; Turley SJ; Müller S
    Nat Commun; 2023 Aug; 14(1):4703. PubMed ID: 37543621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors.
    Espinosa-Carrasco G; Scrivo A; Zumbo P; Dave A; Betel D; Hellmann M; Burt BM; Lee HS; Schietinger A
    bioRxiv; 2023 Jul; ():. PubMed ID: 37461721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
    Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors.
    Harmon C; Zaborowski A; Moore H; St Louis P; Slattery K; Duquette D; Scanlan J; Kane H; Kunkemoeller B; McIntyre CL; Scannail AN; Moran B; Anderson AC; Winter D; Brennan D; Brehm MA; Lynch L
    Nat Cancer; 2023 Aug; 4(8):1122-1137. PubMed ID: 37474835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallmarks of CD8
    Rudloff MW; Zumbo P; Favret NR; Roetman JJ; Detrés Román CR; Erwin MM; Murray KA; Jonnakuti ST; Dündar F; Betel D; Philip M
    Nat Immunol; 2023 Sep; 24(9):1527-1539. PubMed ID: 37537361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
    O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
    Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 tail fusion enhances CAR-T antitumor immunity.
    Zhou X; Cao H; Fang SY; Chow RD; Tang K; Majety M; Bai M; Dong MB; Renauer PA; Shang X; Suzuki K; Levchenko A; Chen S
    Nat Immunol; 2023 Sep; 24(9):1499-1510. PubMed ID: 37500885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity.
    Liang S; Tran E; Du X; Dong J; Sudholz H; Chen H; Qu Z; Huntington ND; Babon JJ; Kershaw NJ; Zhang ZY; Baell JB; Wiede F; Tiganis T
    Nat Commun; 2023 Jul; 14(1):4524. PubMed ID: 37500611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential.
    Bao L; Zhu P; Mou Y; Song Y; Qin Y
    Front Immunol; 2023; 14():1214675. PubMed ID: 37483603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance.
    Krykbaeva I; Bridges K; Damsky W; Pizzurro GA; Alexander AF; McGeary MK; Park K; Muthusamy V; Eyles J; Luheshi N; Turner N; Weiss SA; Olino K; Kaech SM; Kluger HM; Miller-Jensen K; Bosenberg M
    Cancer Immunol Res; 2023 Oct; 11(10):1332-1350. PubMed ID: 37478171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating imputation methods for single-cell RNA-seq data.
    Cheng Y; Ma X; Yuan L; Sun Z; Wang P
    BMC Bioinformatics; 2023 Jul; 24(1):302. PubMed ID: 37507764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.